BHVS

The BHVS welcomes the publication of clinical guidance from NICE on the investigation and management of heart valve disease in adults. This is a first step in the right direction towards improving care across the UK for patients with heart valve disease. The statement below is our Society’s formal

BHVS is delighted to have collaborated with the British Cardiovascular Society (BCS) and the Society for Cardiothoracic Surgery (SCTS) to produce a Joint Statement regarding enhanced follow-up for patients with a Trifecta aortic valve replacement, following an advisory safety warning issued in

BHVS is delighted to have collaborated with the British Cardiovascular Society (BCS), Society for Cardiothoracic Surgery (SCTS), British Congenital Cardiac Association (BCCA), British Society of Echocardiography (BSE) and the Primary Care Cardiovascular Society (PCCS) to produce a Joint Statement on

On July 14th 2021, a National Patient Safety Alert was issued by NHS England relating to choice of anticoagulant drugs prescribed to patients with mechanical heart valves.1 This was triggered by cases presenting to hospital of patients that had been switched from anticoagulation with warfarin to a

Recently, BHVS President Dr Benoy Shah was invited to comment on an upcoming review article due to be published in JACC Intervention regarding TAVI in younger patients. The article set out in a systematic fashion the challenges and unknowns for TAVI in this patient population before presenting data